|
C19ORF55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098190E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.643600E-02 |
| Normal-vs-Stage2 |
1.525610E-01 |
| Normal-vs-Stage3 |
1.334960E-01 |
| Normal-vs-Stage4 |
4.821800E-01 |
| Stage1-vs-Stage2 |
5.763200E-01 |
| Stage1-vs-Stage3 |
8.065600E-01 |
| Stage1-vs-Stage4 |
6.999600E-01 |
| Stage2-vs-Stage3 |
7.787400E-01 |
| Stage2-vs-Stage4 |
5.060600E-01 |
| Stage3-vs-Stage4 |
5.986200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.940920E-03 |
| Normal-vs-AfricanAmerican |
7.018100E-02 |
| Normal-vs-Asian |
8.730600E-01 |
| Caucasian-vs-AfricanAmerican |
5.537200E-01 |
| Caucasian-vs-Asian |
4.648800E-01 |
| AfricanAmerican-vs-Asian |
5.605600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.196350E-02 |
| Normal-vs-Female |
5.160000E-04 |
| Male-vs-Female |
5.024100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.887960E-01 |
| Normal-vs-Extreme_Weight |
3.447200E-01 |
| Normal-vs-Obese |
1.216400E-03 |
| Normal-vs-Extreme_Obese |
8.366000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.811200E-01 |
| Normal_Weight-vs-Obese |
1.271160E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.586200E-01 |
| Extreme_Weight-vs-Obese |
1.540110E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.679400E-01 |
| Obese-vs-Extreme_Obese |
1.526550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.700700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.12130000000799E-05 |
| Normal-vs-Age(61-80Yrs) |
1.081440E-01 |
| Normal-vs-Age(81-100Yrs) |
5.436800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.475000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.891700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.844700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.482490E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.390000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.406000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.5877000000022E-05 |
| Normal-VS-Type2 PRCC |
6.669600E-01 |
| Normal-VS-KIRP CIMP |
2.954100E-02 |
| Normal-VS-Unclassified PRCC |
3.363600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.21629999999085E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.336800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.894200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.791000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.126270E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.246560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.591800E-01 |
| Normal-vs-N1 |
9.938400E-03 |
| Normal-vs-N2 |
6.755200E-01 |
| N0-vs-N1 |
1.633740E-02 |
| N0-vs-N2 |
5.579000E-01 |
| N1-vs-N2 |
5.105400E-01 |
|
|
